Clinical Trials on AOD Misuse

Total 416169 results

Italian Sarcoma Group

Completed

Sorafenib in Relapsed High Grade Osteosarcoma

Osteosarcoma

Italy
National Cancer Institute (NCI)

Completed

Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III Study

Osteosarcoma

United States
Oslo University Hospital

Recruiting

Fibroids and Infertility - a Study of the Significance of Removal of Fibroids With Regard to Endometrial Receptivity (FIN)

Leiomyoma, Uterine

Norway
Kanuni Sultan Suleyman Training and Research Hospital

Completed

Myomectomy Operation and Fundus Incision, Energy Modalities and Methods of Extraction

Surgery | Myoma;Uterus

Turkey
Takeda

Completed

A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.

Uterine Fibroids
St. Jude Children's Research Hospital

Withdrawn

Markers of Anthracycline-Related Cardiac Muscle Injury

Osteosarcoma | Rhabdomyosarcoma | Ewing's Sarcoma Family of Tumors | Non-rhabdomyosarcoma Soft Tissue Sarcomas
IceCure Medical Ltd.

Completed

ICE-SENSE™ Cryotherapy for Breast Fibroadenoma Trial (ICE-CRYSTAL)

Fibroadenoma

Czechia, Germany, Israel
Zealand University Hospital

Unknown

2-D and 3-D Laparoscopic Hysterectomy

Fibroma, Bleeding

Denmark
National Taiwan University Hospital
Taipei Veterans General Hospital, Taiwan

Active, not recruiting

Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma (LEADER)

Advanced Cancer | Leiomyosarcoma | Soft Tissue Sarcoma Adult | Liposarcoma

Taiwan
Memorial Sloan Kettering Cancer Center

Recruiting

Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma

Sarcoma | Soft Tissue Sarcoma | Bone Sarcoma

United States
Zagazig University

Completed

Vasopressin Injection Versus Misoprostol During Hysteroscopic Myomectomy In Reducing Blood Loss And Operation Time.

Submucous Leiomyoma of Uterus
ahmed nagy shaker ramadan

Unknown

the Effect of Misoprostol on Intra-operative Blood Loss During Myomectomy Operation

Blood Loss | Myoma;Uterus

Egypt
National Cancer Institute (NCI)

Completed

Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue Sarcoma

Recurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Adult Synovial Sarcoma

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Withdrawn

Fluorothymidine F-18 PET in Diagnosing Patients With Intermediate or High Grade Soft Tissue Sarcoma

Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Stage II Adult Soft Tissue Sarcoma | Stage IIA Adult Soft Tissue Sarcoma | Stage IIB Adult Soft Tissue Sarcoma | Stage IIC Adult Soft Tissue Sarcoma
University of Cagliari
Azienda Ospedaliera Ordine Mauriziano di Torino; University of Foggia; Civic... and other collaborators

Recruiting

OPPIuM Technique and Myolysis With Diode Laser Dwls (Myolysis)

Uterine Fibroid | Myoma;Uterus

Italy
Ospedale Policlinico San Martino

Recruiting

Predictive Factors for Complete Myoma Resection During Hysteroscopic Myomectomy

Uterine Fibroids | Uterine Myomas

Italy
Johns Hopkins University
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Recruiting

Effects of Simvastatin on Uterine Leiomyoma Size

Leiomyoma | Fibroid Uterus | Leiomyoma, Uterine | Fibroid Tumor | Fibromyoma

United States
Massachusetts General Hospital
Jazz Pharmaceuticals

Recruiting

Lurbinectedin + Doxorubicin In Leiomyosarcoma

Advanced Soft-tissue Sarcoma | Metastatic Soft-tissue Sarcoma | Advanced Leiomyosarcoma | Leiomyosarcoma Metastatic

United States
University College, London
Cancer Research UK; NCRI Radiotherapy Trials QA (RTTQA) Group

Completed

A Study of IMRT in Primary Bone and Soft Tissue Sarcoma (IMRiS)

Ewing Sarcoma | Chordoma | Bone Sarcoma | Soft Tissue Sarcoma, Adult

United Kingdom, Ireland
Second Affiliated Hospital, School of Medicine,...
Peking University People's Hospital; Qilu Hospital of Shandong University; Ruijin... and other collaborators

Not yet recruiting

A Study of Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma

Osteosarcoma

China, Korea, Republic of
Power Life Sciences Inc.

Not yet recruiting

Assessing Clinical Trial Experiences of Patients With Osteosarcoma

Osteosarcoma
University College, London
Bone Cancer Research Trust

Recruiting

ICONIC: Improving Outcomes Through Collaboration in OsteosarComa (ICONIC)

Osteosarcoma

United Kingdom
Peking University People's Hospital

Not yet recruiting

Patient-derived Xenograft (PDX) Modeling to Test Drug Response for High-grade Osteosarcoma

Osteosarcoma
Sun Yat-sen University
Guangdong Provincial Hospital of Traditional Chinese Medicine; Qilu Hospital... and other collaborators

Recruiting

Clinical Trial of Lithium Carbonate Combined With Neo-adjuvant Chemotherapy to Treat Osteosarcoma (Li2CO3)

Osteosarcoma

China
Italian Sarcoma Group

Completed

ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma (ISG/OS-2)

Osteosarcoma

Italy
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma

Osteosarcoma

United States, Canada, Australia, New Zealand, Puerto Rico
Peking University People's Hospital
Jiangsu HengRui Medicine Co., Ltd.; OrigiMed

Completed

Cancer Genome Study Using Samples From Patients Treated on Clinical Trial SHR1020-SHR-1210-II-OS (CSSG-02)

Osteosarcoma

China
Federico II University

Completed

Optical Coherence Tomography Angiography and Choroidal Osteoma

Choroidal Osteoma, Bilateral

Italy
Istituto Ortopedico Rizzoli

Completed

The Prognostic Value of Serum Biomarkers in Osteosarcoma

Osteosarcoma

Italy
Duke University

Completed

Monocyte Phenotypic and Functional Differences

Osteosarcoma

United States
Millennium Pharmaceuticals, Inc.

Terminated

Surveillance Study of Patients With Newly Diagnosed Osteosarcoma

Osteosarcoma

Austria
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Genetic Biomarkers in Tissue Samples From Patients With Osteosarcoma

Osteosarcoma

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma

Sarcoma
Broto, Javier Martín, M.D.

Completed

Trial With Gemcitabine and Rapamycin in Second Line of Metastatic Osteosarcoma (GEIS-29)

Osteosarcoma
BTG International Inc.
M.D. Anderson Cancer Center

Terminated

High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma

Osteosarcoma
M.D. Anderson Cancer Center

Terminated

Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy

Osteosarcoma

United States
Millennium Pharmaceuticals, Inc.

Completed

Mifamurtide (L-MTP-PE) for High-Risk Osteosarcoma

Osteosarcoma

United States
European Organisation for Research and Treatment...
Medical Research Council

Completed

Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma

Sarcoma

France, Saudi Arabia, Denmark, Belgium, Netherlands, Portugal, Slovenia, United Kingdom
Eli Lilly and Company

Completed

Chemotherapy for Patients With Osteosarcoma

Osteosarcoma

Germany, Spain, France, Italy, United Kingdom
St. Jude Children's Research Hospital
National Institutes of Health (NIH); Immunex/Berlex

Completed

Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma

Osteosarcoma

United States, Chile
Mayo Clinic
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients Undergoing Surgery for Newly Diagnosed High-Grade Osteosarcoma

Sarcoma
Stanford University

Recruiting

Pediatric PET/MR Image Registry

Lymphoma | Osteosarcoma | Soft Tissue

United States
Azienda Ospedaliera S. Maria della Misericordia

Completed

GnRH Agonist Pretreatment in Hysteroscopic Myomectomy

Uterine Myoma

Italy
Seattle Children's Hospital
Umoja BioPharma, Inc.

Recruiting

A Phase I Feasibility And Safety Study of Fluorescein-Specific (FITC-E2) CAR T Cells In Combination With Parenterally Administered Folate-Fluorescein (UB-TT170) For Osteogenic Sarcoma

Osteosarcoma

United States
National Cancer Institute (NCI)

Completed

Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma

Metastatic Osteosarcoma

United States
University Hospital, Strasbourg, France

Completed

Genetic Characterisation of High-grade Paediatric Osteosarcomas

Paediatric Osteosarcomas

France
Boehringer Ingelheim

Not yet recruiting

Brightline-3: A Study to Find Out Whether Brigimadlin in Combination With Ezabenlimab Helps People With Advanced Soft Tissue Sarcoma

Advanced Soft Tissue Sarcoma | Undifferentiated Pleomorphic Sarcoma (UPS) | Myxofibrosarcoma (MFS)
Sarcoma Alliance for Research through Collaboration

Completed

SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes

Liposarcoma | Osteogenic Sarcoma | Ewing/Ewing-like Sarcoma | Rhabdomyosarcoma | Mesenchymal Chondrosarcoma

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma

Recurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Adult Angiosarcoma

United States
Northwestern University
National Cancer Institute (NCI); Bayer

Completed

Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma

Recurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Adult Angiosarcoma

United States

Clinical Trials on AOD Misuse

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations